Pharmalot… Pharmalittle… The Weekend Nears
Make a commentBy Ed Silverman // October 10th, 2008 // 5:50 am
Hello, everyone. Nice to see you again. Our day off was well spent, but now, the routine beckons. You may notice that we are playing catch up, so a few posts attempt to cover news that emerged yesterday, but we feel the need to go on record with some developments. Of course, there is also fresh news, as well. So grab a cup of something stimulating and dig in…
Novartis’ Dan Vasella Visits Alcon (Fort Worth Star-Telegram)
Mylan CEO Says Drugmaker Is Doing Fine (Pittsburgh Tribune-Review)
Almylan Buyout Unlikely To Materialize Soon (Dow Jones)
Biogen Discontinues Experimental Arthritis Drug (Reuters)
Biovail Faces New Class-Action Shareholder Suit (Financial Post)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Alcon, Alnylam Pharmaceuticals, Biogen, Dan Vasella, Mylan Laboratories, Novartis